Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q2 2020 · 10-Q
Revenue$184.93M$184.93M+6.0% vs Q2 2019 Net Income$119.62M$119.62M+581.4% vs Q2 2019 EPS Diluted$3.02$3.02+571.1% vs Q2 2019 Gross Profit$121,403,000+7.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$70,418,000+51.2% Free Cash Flowderived$55,854,000+33.1% Margins · derivedGross margin65.6%+0.9 pt vs Q2 2019
Operating margin20.0%+0.7 pt vs Q2 2019
Net margin64.7%+54.6 pt vs Q2 2019
ended Dec 31, 2019 · filed Feb 6, 2020 · 37 d after period end